Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure–activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 13, pp. 3857-3863
Closed Access | Times Cited: 13

Showing 13 citing articles:

Copper-Promoted Trifluoromethanesulfonylation and Trifluoromethylation of Arenediazonium Tetrafluoroborates with NaSO2CF3
Ke Zhang, Xiu‐Hua Xu, Feng‐Ling Qing
The Journal of Organic Chemistry (2015) Vol. 80, Iss. 15, pp. 7658-7665
Closed Access | Times Cited: 87
Asymmetric synthesis of tetrahydroisoquinolines by enzymatic Pictet–Spengler reaction
Masakatsu Nishihachijo, Yoshinori Hirai, Shigeru Kawano, et al.
Bioscience Biotechnology and Biochemistry (2014) Vol. 78, Iss. 4, pp. 701-707
Open Access | Times Cited: 62
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Distinct effects of IPSU and suvorexant on mouse sleep architecture
Daniël Hoyer, Thomas Dürst, Markus Fendt, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 39
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 9, pp. 1884-1891
Closed Access | Times Cited: 31
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach
Bibia Heidmann, John Gatfield, Catherine Roch, et al.
ChemMedChem (2016) Vol. 11, Iss. 19, pp. 2132-2146
Closed Access | Times Cited: 17
Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure–activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 4, pp. 1201-1208
Closed Access | Times Cited: 16
Synthesis of Triazolo- and Oxadiazolopiperazines by Gold(I)-Catalyzed Domino Cyclization: Application to the Design of a Mitogen Activated Protein (MAP) Kinase Inhibitor
Koki Yamamoto, Yasushi Yoshikawa, Masahito Ohue, et al.
Organic Letters (2018) Vol. 21, Iss. 2, pp. 373-377
Closed Access | Times Cited: 14
Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure–Activity Relationships, and Sleep‐Promoting Properties in Rats
Christine Brotschi, Catherine Roch, John Gatfield, et al.
ChemMedChem (2019) Vol. 14, Iss. 13, pp. 1257-1270
Closed Access | Times Cited: 10
Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
Jodi T. Williams, John Gatfield, Catherine Roch, et al.
MedChemComm (2015) Vol. 6, Iss. 6, pp. 1054-1064
Closed Access | Times Cited: 9
Chemical tagging of chlorinated phenols for their facile detection and analysis by NMR spectroscopy
Carlos A. Valdez, Roald N. Leif
Analytical and Bioanalytical Chemistry (2015) Vol. 407, Iss. 13, pp. 3539-3543
Closed Access | Times Cited: 6
From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved in vivo Efficacy in Dogs
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 430-448
Closed Access | Times Cited: 6
Orexin Receptor Antagonists
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
Page 1

Scroll to top